Adopting New Medical Technology
National Academies Press, Jan 15, 1994 - Medical - 223 pages
What information and decisionmaking processes determine how and whether an experimental medical technology becomes accepted and used?
Adopting New Medical Technology reviews the strengths and weaknesses of present coverage and adoption practices, highlights opportunities for improving both the decisionmaking processes and the underlying information base, and considers approaches to instituting a much-needed increase in financial support for evaluative research.
Essays explore the nature of technological change; the use of technology assessment in decisions by health care providers and federal, for-profit, and not-for-profit payers; the role of the courts in determining benefits coverage; strengthening the connections between evaluative research and coverage decisionmaking; manufacturers' responses to the increased demand for outcomes research; and the implications of health care reform for technology policy.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
adoption AHCPR American Medical Association appropriate approval benefits Blue Cross bone marrow transplantation breast cancer Center cholecystectomy clinical trials Committee companies conducted consumers cost-effectiveness COVERAGE DECISIONMAKING coverage decisions Cross and Blue diagnostic diffusion disease economic effectiveness efficacy England Journal ofMedicine evaluative research example experimental federal Gelijns groups HCFA HDC-ABMT health care costs health care expenditures Health Care Financing health care insurance health care reform health care system Health Care Technology health insurance HEALTH MAINTENANCE ORGANIZATION health policy Health Services Research HMOs hospital managers incentives increase Institute of Medicine insurance system issues Kaiser Permanente medical innovation medical technology Medicare myocardial infarction National nonprofit organ transplants outcomes data outcomes research patient outcomes percent physicians plans pricing procedures providers R&D sector reimbursement retrospective role society stage studies surgery technological change technology assessment therapy treatment U.S. Congress utilization Weisbrod